IMeBIO

At IMeBIO, we design, manufacture, and market mobile BSL2 and BSL3 biological containment labs for organizations involved in the study of pathogens, whether to fight bioterrorism, pandemics, or other public health risks. 
Founded in December 2008, IMeBIO has two key objectives: 
- to provide optimal protection for laboratory staff as well as the people working and living near biological containment labs 
- to meet the need for safe, robust, and rapidly-deployable biological research facilities-especially in countries with outbreaks of virulent strains.
 Our mobile labs can be set up in a fraction of the time it takes to build a permanent laboratory, meaning that critical R&D work can begin almost immediately.
One of our company's key investors is Institut Mérieux, a French industrial biology company committed to fighting infectious diseases and cancers around the world.